Woojung Bio (XKRX:215380) Total Assets : ₩98,333 Mil (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Woojung Bio Total Assets?

Woojung Bio's Total Assets for the quarter that ended in Dec. 2023 was ₩98,333 Mil.

Warning Sign:

If a company builds assets at 29% a year, faster than its revenue growth rate of 5.7% over the past 5 years, it means that the company may be getting less efficient.

During the past 12 months, Woojung Bio's average Total Assets Growth Rate was 2.90% per year. During the past 3 years, the average Total Assets Growth Rate was 19.80% per year. During the past 5 years, the average Total Assets Growth Rate was 29.00% per year.

During the past 9 years, Woojung Bio's highest 3-Year average Total Assets Growth Rate was 522.90%. The lowest was 19.80%. And the median was 37.95%.

Total Assets is connected with ROA %. Woojung Bio's annualized ROA % for the quarter that ended in Dec. 2023 was 13.04%. Total Assets is also linked to Revenue through Asset Turnover. Woojung Bio's Asset Turnover for the quarter that ended in Dec. 2023 was 0.18.

Woojung Bio Total Assets Historical Data

The historical data trend for Woojung Bio's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Woojung Bio Total Assets Chart

Woojung Bio Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Assets

Get a 7-Day Free Trial

57,631.95

69,816.02

100,136.14

94,993.77

98,332.60

Woojung Bio Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Assets	Get a 7-Day Free Trial															94,993.77	91,936.03	95,546.10	96,726.79	98,332.60

Woojung Bio Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Woojung Bio's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (A: Dec. 2023 )	+	Total Liabilities (A: Dec. 2023 )
	=	21972.072	+	76360.532
	=	98,333

Woojung Bio's Total Assets for the quarter that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (Q: Dec. 2023 )	+	Total Liabilities (Q: Dec. 2023 )
	=	21972.072	+	76360.532
	=	98,333

Woojung Bio (XKRX:215380) Total Assets Explanation

Total Assets is connected with ROA %.

Woojung Bio's annualized ROA % for the quarter that ended in Dec. 2023 is

ROA %	=	Net Income (Q: Dec. 2023 )	/	( (Total Assets (Q: Sep. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
	=	12720.42	/	( (96726.79	+	98332.604)	/ 2 )
	=	12720.42	/	97529.697
	=	13.04 %

Note: The Net Income data used here is four times the quarterly (Dec. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Woojung Bio's Asset Turnover for the quarter that ended in Dec. 2023 is

	Asset Turnover
=	Revenue (Q: Dec. 2023 )	/	( (Total Assets (Q: Sep. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
=	17904.259	/	( (96726.79	+	98332.604)	/ 2 )
=	17904.259	/	97529.697
=	0.18

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Woojung Bio Total Assets Related Terms

Thank you for viewing the detailed overview of Woojung Bio's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Woojung Bio (XKRX:215380) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Woojung Bio Inc (XKRX:215380) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

Gwanggyo-ro 145, B-dong 3rd Floor, Next Generation Convergence Technology Research Center, Gyeonggi-do, Yeongtong-gu, Suwon-si, KOR

Website

http://bio.woojungbsc.co.kr

Woojung Bio Inc is engaged in the research and development of natural science and engineering. Its products include Gene Delivery, Antibody Production, Immunodeficiency model, Human-to-human model, Zika, Mers, Dengue, Influenza Virus Research, Influenza virus, vaccine studies, and Elegant Goettingen Mini Pig.

Woojung Bio (XKRX:215380) Headlines

No Headlines